Post

India's Sun Pharma Expects to Win in China

India's Sun Pharma Expects to Win in China

With a recovery underway in its U.S. business, India’s Mumbai-based Sun Pharmaceutical Industries Ltd., is scouting for a partner in China, where the government aims to drive down the cost of healthcare.

China has rolled out a bulk drug procurement program that’s driving down prices and providing an opening for Indian manufacturers to compete. The country is importing more drugs, reimbursing for more, and speeding up approvals of new medicines to ensure they reach patients faster.

medication

Sun Pharma’s founder Dilip Shanghvi told Bloomberg News’ editor-in-chief John Micklethwait, “There is a big opportunity for us. We see enormous interest in China for products that we have global rights for.” According to Shanghvi, the company will scale up its China business in six to nine months.

Share

About Amritt

Who We Are

Small or big, your business will love our financial help and business consultations! We are happy when our clients are too… Actually, this is quite simple to achieve – because each time we help them in sorting out different accounting intricacies or save the day before filing the taxes, they are happy indeed! And so are we.   

We have over Twenty years of experience helping our clients succeed in India

Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Blog
Page
Dictionary
Comparisons
Capabilities
India Business Guide
Services
Private
Speaking
Insights
White Papers
News
Newsletters
Clients
Case Studies
Companies In India
Webinars
Presentations
Industries